Literature DB >> 9926409

Identification of in vitro metabolites of Indinavir by "intelligent automated LC-MS/MS" (INTAMS) utilizing triple quadrupole tandem mass spectrometry.

X Yu1, D Cui, M R Davis.   

Abstract

In an effort to improve the efficiency of the TSQ 7000 LC-MS/MS system for identification of drug metabolites in biological matrices in support of drug discovery programs, a combination of instrument control language procedures for the Finnigan MAT TSQ 7000 mass spectrometer, referred to as INTAMS, were composed. INTAMS was designed to conduct unattended, automatic liquid chromatography/mass spectrometry (LC-MS) and LC-MS/MS analyses of drugs and metabolites in commonly encountered in vitro biological matrices. A novel peak detection algorithm was developed to automatically detect and record the pseudomolecular ions and retention times of chromatographic components, even if not fully resolved. This algorithm was used in combination with an automated technique for predicting the molecular weights of metabolites based on incremental changes of the molecular weight of the parent drug resulting from well-known biotransformation processes. When applied to a sample of an incubation mixture of the HIV protease inhibitor Indinavir with a rat liver S9 preparation, the results obtained by the automatic metabolite detection procedures for LC-MS and LC-MS/MS analyses in real time were the same as those which were determined manually, by a knowledgeable operator.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9926409     DOI: 10.1016/S1044-0305(98)00132-9

Source DB:  PubMed          Journal:  J Am Soc Mass Spectrom        ISSN: 1044-0305            Impact factor:   3.109


  9 in total

Review 1.  Application of metabolism and pharmacokinetic studies to the drug discovery process.

Authors:  M J Humphrey
Journal:  Drug Metab Rev       Date:  1996-08       Impact factor: 4.518

2.  The simultaneous determination of mixtures of drug candidates by liquid chromatography/atmospheric pressure chemical ionization mass spectrometry as an in vivo drug screening procedure.

Authors:  T V Olah; D A McLoughlin; J D Gilbert
Journal:  Rapid Commun Mass Spectrom       Date:  1997       Impact factor: 2.419

3.  Simultaneous pharmacokinetic screening of a mixture of compounds in the dog using API LC/MS/MS analysis for increased throughput.

Authors:  J Berman; K Halm; K Adkison; J Shaffer
Journal:  J Med Chem       Date:  1997-03-14       Impact factor: 7.446

4.  A direct technique for the simultaneous determination of 10 drug candidates in plasma by liquid chromatography-atmospheric pressure chemical ionization mass spectrometry interfaced to a Prospekt solid-phase extraction system.

Authors:  D A McLoughlin; T V Olah; J D Gilbert
Journal:  J Pharm Biomed Anal       Date:  1997-08       Impact factor: 3.935

5.  Rapid structure elucidation of catecholamine conjugates with tandem mass spectrometry.

Authors:  P Rudewicz; K M Straub
Journal:  Anal Chem       Date:  1986-12       Impact factor: 6.986

6.  Species differences in the pharmacokinetics and metabolism of indinavir, a potent human immunodeficiency virus protease inhibitor.

Authors:  J H Lin; M Chiba; S K Balani; I W Chen; G Y Kwei; K J Vastag; J A Nishime
Journal:  Drug Metab Dispos       Date:  1996-10       Impact factor: 3.922

Review 7.  Applications of combinatorial technologies to drug discovery. 2. Combinatorial organic synthesis, library screening strategies, and future directions.

Authors:  E M Gordon; R W Barrett; W J Dower; S P Fodor; M A Gallop
Journal:  J Med Chem       Date:  1994-05-13       Impact factor: 7.446

Review 8.  Applications of combinatorial technologies to drug discovery. 1. Background and peptide combinatorial libraries.

Authors:  M A Gallop; R W Barrett; W J Dower; S P Fodor; E M Gordon
Journal:  J Med Chem       Date:  1994-04-29       Impact factor: 7.446

9.  Disposition of indinavir, a potent HIV-1 protease inhibitor, after an oral dose in humans.

Authors:  S K Balani; E J Woolf; V L Hoagland; M G Sturgill; P J Deutsch; K C Yeh; J H Lin
Journal:  Drug Metab Dispos       Date:  1996-12       Impact factor: 3.922

  9 in total
  4 in total

Review 1.  Mass spectrometry innovations in drug discovery and development.

Authors:  D I Papac; Z Shahrokh
Journal:  Pharm Res       Date:  2001-02       Impact factor: 4.200

2.  Liquid chromatography-tandem mass spectrometry analysis of anisodamine and its phase I and II metabolites in rat urine.

Authors:  Huaixia Chen; Hong Wang; Yong Chen; Huashan Zhang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2005-09-25       Impact factor: 3.205

Review 3.  Tandem mass spectrometry of small-molecule antiviral drugs: 1. HIV-related antivirals.

Authors:  W M A Niessen
Journal:  Int J Mass Spectrom       Date:  2020-06-15       Impact factor: 1.986

4.  Identification of 3',4'-Dimethoxy Flavonol-3-β-d-Glucopyranoside Metabolites in Rats by Liquid Chromatography-Electrospray Ionization Ion Trap Mass Spectrometry.

Authors:  Yuan Zhu; Jun Wen; Yuqing Cao; Yuanying Jiang; Jinghua Huang; Guorong Fan; Yuefen Lou
Journal:  Molecules       Date:  2016-04-09       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.